Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-13

Clinical Trial Update: Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing medroxyprogesterone acetate with venlafaxine for hot flashes in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Medroxyprogesterone acetate (Medroxyprogesterone acetate)
  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED